The Potential of Cannabidiol for Treating Canine Atopic Dermatitis
Veterinary Sciences,
Journal Year:
2025,
Volume and Issue:
12(2), P. 159 - 159
Published: Feb. 12, 2025
Atopic
dermatitis
is
prevalent
in
humans
(hAD)
and
dogs
(cAD)
profoundly
impacts
the
patients’
quality
of
life.
The
increasing
number
new
drugs
development
for
atopic
indicates
both
need
potential
precision
medicine
to
generate
an
optimised
benefit–risk
therapeutic
plan.
Cannabidiol
(CBD),
known
its
anti-inflammatory
antipruritic
properties,
shows
promise
hAD
cAD
management,
prompting
exploration
cannabinoids
(CBs)
CBD
as
tools.
In
fact,
encouraging
results
on
benefits
using
have
been
published,
along
with
safety
evaluations
that
reveal
generally
well
tolerated
dogs.
However,
limited
placebo-controlled
trials
dosage
variations
pose
barriers
hinder
definitive
conclusions.
Challenges
product
stability,
inconsistent
formulations,
legal
ambiguities
highlight
standardised
CBD-based
products
research
commercial
uses.
complex
landscape
further
complicates
accessibility
regulation.
Despite
these
challenges,
emerging
a
avenue
urging
high-quality
research,
clarity.
This
brief
review
provides
valuable
insights
into
CBs
cAD,
compared
hAD,
emphasising
importance
rigorous
unambiguous
regulation
successful
integration
veterinary
dermatology.
Language: Английский
GC–MS as a valuable tool for analysing cannabinoid-containing gummies and identifying the synthetic process used for their production
Forensic Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown, P. 100672 - 100672
Published: May 1, 2025
Language: Английский
Fragmentation and Isomerization Pathways of Natural and Synthetic Cannabinoids Studied via Higher Collisional Energy Dissociation Profiles
Molecules,
Journal Year:
2025,
Volume and Issue:
30(3), P. 717 - 717
Published: Feb. 5, 2025
Cannabinoid
molecules
are
the
family
of
that
bind
to
cannabinoid
receptors
(CB1
and
CB2)
human
body
cause
changes
in
numerous
biological
functions
including
motor
coordination,
emotion,
pain
reception.
Cannabinoids
occur
either
naturally
Cannabis
Sativa
plant
or
can
be
produced
synthetically
laboratory.
The
need
for
accurate
analytical
methods
analyzing
is
considerable
current
importance
due
demands
detecting
illegal
cannabinoids
monitoring
manufacture
popular,
non-illegal
products.
Mass
spectrometry
has
been
shown
an
optimum
technique
identifying
cannabinoids.
In
this
work,
we
perform
Higher
Collisional
Dissociation
(HCD)
mass
spectrometric
measurements
on
Orbitrap
Fusion
Tribrid
Spectrometer
measure
collision-energy-dependent
molecular
fragmentation
pathways
a
group
key
their
metabolites
(cannabidiol,
Δ9-Tetrahydrocannabinol,
11-Hydroxy-Δ9-tetrahydrocannabinol,
11-nor-9-Carboxy-Δ9-tetrahydrocannabinol,
cannabidiolic
acid,
tetrahydrocannabinolic
acid),
along
with
two
synthetic
(JWH-018
MDMB-FUBINACA).
This
first
time
have
studied
using
energy-resolved
HCD
methods.
We
identified
number
common,
primary
pathways,
loss
water,
other
small
neutral
molecule
units
(e.g.,
butene),
rupture
central
C-C
bond
links
aromatic
alkyl
ring
groups.
Quantum
chemical
calculations
presented
provide
insights
into
preferred
protonation
sites
characterize
isomerization
protonated
open-ring
[CBDA
+
H]+)
closed-ring
analogues
[THCA
H]+).
A
result
emerge
from
our
study
particularly
valuable
isomerization,
since
isobaric
pairs
ions
here
H]+
associated
identical
profiles
indicating
one
structure
occurred
during
electrospray–mass
process.
important
as
it
will
general
applicability
tautomeric
thus
demonstrates
application
tool
tautomerization
proclivity.
Language: Английский
Exploring the Potential of Nonpsychoactive Cannabinoids in the Development of Materials for Biomedical and Sports Applications
Dulexy Solano-Orrala,
No information about this author
Dennis A. Silva-Cullishpuma,
No information about this author
Eliana Díaz-Cruces
No information about this author
et al.
ACS Applied Bio Materials,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 20, 2024
This
Perspective
explores
the
potential
of
nonpsychoactive
cannabinoids
(NPCs)
such
as
CBD,
CBG,
CBC,
and
CBN
in
developing
innovative
biomaterials
for
biomedical
sports
applications.
It
examines
their
physicochemical
properties,
anti-inflammatory,
analgesic,
neuroprotective
effects,
integration
into
various
hydrogels,
sponges,
films,
scaffolds.
also
discusses
current
challenges
standardizing
formulations,
understanding
long-term
intrinsical
regulatory
landscapes.
Further,
it
promising
applications
NPC-loaded
materials
bone
regeneration,
wound
management,
drug
delivery
systems,
emphasizing
improved
biocompatibility,
mechanical
therapeutic
efficacy
demonstrated
Language: Английский